PARAGARD T 380A Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paragard T 380a, and when can generic versions of Paragard T 380a launch?
Paragard T 380a is a drug marketed by Coopersurgical and is included in one NDA.
The generic ingredient in PARAGARD T 380A is copper. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the copper profile page.
Summary for PARAGARD T 380A
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 2869 |
Clinical Trials: | 13 |
Patent Applications: | 404 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in PARAGARD T 380A? | PARAGARD T 380A excipients list |
DailyMed Link: | PARAGARD T 380A at DailyMed |
Recent Clinical Trials for PARAGARD T 380A
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
United States Agency for International Development (USAID) | Phase 4 |
Kenya Medical Research Institute | Phase 4 |
Eastern Virginia Medical School | Phase 4 |
Pharmacology for PARAGARD T 380A
Drug Class | Copper-containing Intrauterine Device |
Physiological Effect | Decreased Embryonic Implantation Decreased Sperm Motility Inhibit Ovum Fertilization |
US Patents and Regulatory Information for PARAGARD T 380A
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coopersurgical | PARAGARD T 380A | copper | INTRAUTERINE DEVICE;INTRAUTERINE | 018680-001 | Nov 15, 1984 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |